Video

ALK+ Metastatic Non-Small Cell Lung Cancer: The Importance of Biomarker Testing

Author(s):

Jonathan W. Riess, MD, MS, UC Davis Comprehensive Cancer Center

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
image of man.
Dr. Joshua Sabari and Chris Conneran
Picture of Dr. John Oertle
Related Content
clinical trial logo
September 15th 2025

Actively Recruiting Trials for Lung, Biliary, AML and Small Cell Cancer

Spencer Feldman
CURE Cancer Horizons logo
September 15th 2025

FDA Approvals from February 2024

Alex Biese Brielle Benyon
illustration of lungs
September 15th 2025

Tepmetko Associated With Frequent Side Effects for Some With NSCLC

Jax DiEugenio
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
September 15th 2025

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Tamron Little was diagnosed with peritoneal mesothelioma in 2007 as a 21-year-old new mother. Catch up on Tamron's blogs here!
September 15th 2025

Standing Up to Cancer: What it Means to Me

Tamron Little
For patients with advanced non-small cell lung cancer who progressed on two or more prior regimens, THIO with Libtayo elicited positive responses: © stock.adobe.com.
September 15th 2025

THIO Plus Libtayo Elicits Positive Responses in Advanced NSCLC

Alex Biese